Rebecca Ann Brooks, M.D.
Division Director, Gynecologic Oncology
Fellowship Director, Gynecologic Oncology
Professor
To see if Rebecca Ann Brooks is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Specialties
Gynecology Oncology
Surgery - Robotic
Robotic Surgery
Cervical
Endometrial (Uterine)
Ovarian
Department
Locations and Contact
UC Davis Comprehensive Cancer Center
Gynecologic Oncology Clinic
4501 X Street
Sacramento, CA 95817
Phone: 916-734-5959
Philosophy of Care
Dr. Brooks strives to know her patients as people and not as diagnoses. She is a fierce patient advocate and fights to the best of her ability for and alongside her patients. Dr. Brooks truly tries to listen to each patient to understand their perspective and concerns and address them. She strives to empower her patients through education about their diagnosis and understand all treatment options. She uses her expertise to personalize treatment and care delivery in a way individualized for each patient affected by the disease.
Clinical Interests
Dr. Rebecca Brooks is an expert in the comprehensive medical and surgical care of women with uterine, ovarian, cervical, vulvar and vaginal cancers and gestational trophoblastic disease.
She has special interests in the radical pelvic surgery and upper abdominal debulking for advanced cancer as well as robotic surgery. She also has experience with administration of heated intra-abdominal chemotherapy (HIPEC).
Dr. Brooks is highly skilled in systemic therapy for gynecologic malignancies including standard chemotherapy to the use of novel biologic agents. She is committed to maximizing health and quality of life for cancer survivors and those affected by the disease.
Research/Academic Interests
Dr. Brooks' academic focus is an education of gynecologic oncology trainees. She completed a fellowship in medical education at the University of Chicago and functions as a fellowship program director and board examiner.
Dr. Brooks' research interests include mechanisms that affect the likelihood of metastases in endometrial cancer, various clinical topics related to gynecologic oncology, and education research such as mentorship and support mechanisms for trainees and junior faculty. She is also active in clinical trials.
Division
Gynecologic Oncology
Center/Program Affiliation
Undergraduate School
B.S., University of Illinois, Urbana IL 1999
Medical School
M.D., Rush Medical College, Chicago IL 2003
Internship
Obstetrics and Gynecology, Washington University School of Medicine. St. Louis MO 2003-2004
Residency
Obstetrics and Gynecology, Washington University School of Medicine, St. Louis MO 2004-2007
Fellowship
Gynecologic Oncology, Washington University School of Medicine, St. Louis MO 2007-2010
MERITS fellowship in medical education, University of Chicago, 2017
Listed in “Chicago Top Cancer Doctors”, 2016
UCSF Exceptional Faculty Award in Medical Student Teaching 2013, 2014, 2015
Elected Candidate Member Representative, Society of Gynecologic Oncology Council, 2014
UCSF Patient Satisfaction Honor Roll, 2014
Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, Tatebe K, Veneris JL. Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 2019 Jul;69(4):258-279. doi:10.3322/caac.21561. Epub 2019 May 10. PMID:31074865.
Sethi R, Mayadev J, Sethi S, Rash D, Chen LM, Brooks R, Ueda S, Hsu IC. Patterns of Recurrence in Node-Positive Cervical Cancer Patients Treated With Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study. Pract Radiat Oncol. 2019 Mar;9(2):e180-e186. doi:10.1016/j.prro.2018.08.012. Epub 2018 Oct 17. PMID:30342181.
Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients. Am J Obstet Gynecol. 2016 Dec;215(6):766.e1-766.e9. doi:10.1016/j.ajog.2016.07.035. Epub 2016 Jul 22. PMID:27457116.
Chapman JS, Roddy E, Ueda S, Brooks R, Chen LL, Chen LM. Enhanced Recovery Pathways for Improving Outcomes After Minimally Invasive Gynecologic Oncology Surgery. Obstet Gynecol. 2016 Jul;128(1):138-144. doi:10.1097/AOG.0000000000001466. PMID:27275797.
Plett SK, Poder L, Brooks RA, Morgan TA. Transvaginal Ultrasound-Guided Biopsy of Deep Pelvic Masses: How We Do It. J Ultrasound Med. 2016 Jun;35(6):1113-22. doi:10.7863/ultra.15.08002. Epub 2016 Apr 18. PMID:27091918.
Brooks RA, Blansit K, Young-Lin N, Usach I, Chen LM, Yu X, Kapp DS, Chan JK. The economic impact of surgical care for morbidly obese endometrial cancer patients: a nationwide study. Am J Obstet Gynecol. 2016 Apr;214(4):498.e1-498.e6. doi:10.1016/j.ajog.2015.10.015. Epub 2015 Oct 23. PMID:26478102.
Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS. Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer. Gynecol Oncol. 2010 Mar;116(3):539-43. doi:10.1016/j.ygyno.2009.09.037. Epub 2009 Nov 10. PMID:19906411.
Brooks RA, Rader JS, Dehdashti F, Mutch DG, Powell MA, Thaker PH, Siegel BA, Grigsby PW. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol. 2009 Jan;112(1):104-9. doi:10.1016/j.ygyno.2008.08.028. Epub 2008 Oct 16. PMID:18929403.
Brooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, Wall LL. Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. Gynecol Oncol. 2009 Jul;114(1):75-9. doi:10.1016/j.ygyno.2009.03.036. Epub 2009 May 1. PMID:19410279.
Brooks RA, Herzog TJ. Long-term semi-permanent catheter use for the palliation of malignant ascites. Gynecol Oncol. 2006 May;101(2):360-2. doi:10.1016/j.ygyno.2005.12.043. Epub 2006 Feb 24. PMID:16499957.